Concepedia

Additive effect of drospirenone/17-β-estradiol in hypertensive postmenopausal women receiving enalapril1

Richard A. Preston, A ALONSO, D PANZITTA, Ping Zhang, Adel H. Karara

American Journal of Hypertension · 2002 · 53 citations · 25 references

DOIFull text

Open access

Abstract

Our results suggest a significant additive BP-lowering effect of DRSP/E2 on both systolic and diastolic BP in hypertensive postmenopausal women receiving ENA, consistent with an antimineralocorticoid effect. DRSP/E2, a HRT with antimineralocorticoid effects, could offer a novel potential mechanism for reducing cardiovascular end points in postmenopausal women.

References

25

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Bertram Pitt, Faı̈ez Zannad, Willem J. Remme et al. · New England Journal of Medicine · 1999 · 9K citations · Full text

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley · JAMA · 1998 · 6.2K citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Bertram Pitt, Faı̈ez Zannad, Willem J. Remme et al. · Survey of Anesthesiology · 2000 · 2.9K citations

, , +17

Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women

Valery T. Miller · JAMA · 1995 · 2.3K citations

, , +21

Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis

David M. Herrington, David M. Reboussin, K. Bridget Brosnihan et al. · New England Journal of Medicine · 2000 · 1.3K citations · Full text